Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion type Assertion NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_head.
- NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion description "[The prevalence of prothrombin (PT) G20210A and methylenetetrahydrofolate reductase (MTHFR) C677 <-- T was assessed in 40 patients with primary antiphospholipid syndrome (APS) (14 male, 26 female; mean age, 37 +/- 14 years) and in 27 persistent carriers of antiphospholipid antibodies (aPL) (five male, 22 female; mean age, 40 +/- 16 years) without underlying diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_provenance.
- NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion evidence source_evidence_literature NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_provenance.
- NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion SIO_000772 11734671 NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_provenance.
- NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion wasDerivedFrom befree-20150227 NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_provenance.
- NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_assertion wasGeneratedBy ECO_0000203 NP575782.RAKdeL6jpHC5HmpIxcob0NdLhjRG_rdbwXMfO4Lewh0Hk130_provenance.